People channel feed

Lil­ly's di­a­betes and obe­si­ty leader to re­tire in broad­er lead­er­ship shuf­fle as CSO Dan Skovron­sky takes on im­munol­o­gy role

Last year
Pharma

Kezar changes CEOs, lays off 41% of staff and halts pre­clin­i­cal R&D to ex­tend cash run­way

Last year
R&D

The End­points Slack in­ter­view: Celli­no CEO Nabi­ha Sak­layen on cell ther­a­py's fu­ture, Elon Musk and time trav­el

Last year
Startups
Cell/Gene Tx

Flag­ship poach­es an­oth­er phar­ma R&D leader as GSK's Lep­ore heads to Pro­Found

Last year
Startups

Sy­ros lays off 35% of work­ers, re­places CEO and los­es CSO af­ter axed pacts

Last year
R&D

Katal­in Karikó, Drew Weiss­man win No­bel Prize for mR­NA dis­cov­er­ies

Last year

Scoop: Led by for­mer Trump of­fi­cial, Al­te­sa Bio­Sciences rais­es $35M for an­tivi­rals, re­cruits Mon­cef Slaoui to board

Last year
Financing

PTC cuts 25% of its work­force to save mon­ey amid big com­pa­ny re­vamp 

Last year

Ab­cam founder urges in­vestors to vote against Dana­her's $5.7B buy­out, seeks to re­turn as CEO

Last year

Galec­to lays off 70% of staff, con­sid­ers strate­gic al­ter­na­tives af­ter IPF tri­al fail

Last year

Force­field Ther­a­peu­tics to start £35M Se­ries A in Oc­to­ber af­ter scoop­ing ex-No­var­tis ex­ec John Tsai as new CEO

Last year
Financing

No­bel Prize win­ner Demis Has­s­abis talks about his vi­sion for Iso­mor­phic and AI’s fu­ture in biotech

Last year
AI

Pox­el takes write­down on NASH drug as it con­tin­ues lay­offs, search for cash

Last year

Im­mu­ni­ty­Bio lays off 50 em­ploy­ees in Flori­da and Cal­i­for­nia af­ter blad­der can­cer BLA re­jec­tion

Last year

Au­rinia ap­points founder to board in hand­shake with MKT Cap­i­tal

Last year

Up­dat­ed: So­ci­etal CD­MO lays off 26 em­ploy­ees, re­works hir­ing plans af­ter strat­e­gy re­view

Last year
Manufacturing

Ox­ford Bio­med­ica piv­ots by lay­ing off 200 peo­ple, ac­quir­ing ABL Eu­rope amid de­clin­ing to­tal rev­enues

Last year
Manufacturing

NightHawk lays off 14% of R&D work­force, piv­ots to fo­cus on CD­MO Scor­pius Bio­man­u­fac­tur­ing

Last year
Manufacturing

It’s al­most the end of the road for Fresh Tracks as board sup­ports liq­ui­da­tion

Last year
Pharma

Rentschler names Benedikt von Braun­muehl as CEO; Catal­ent grabs David McEr­lane from Lon­za as bi­o­log­ics lead

Last year
Manufacturing

Kin­nate lays off 70% of em­ploy­ees, shaves pipeline to fo­cus on CDK4 and pan-RAF in­hibitor

Last year
R&D

Mer­ck’s women’s health spin­off Organon looks for phar­ma­ceu­ti­cals, di­ag­nos­tics, de­vices to fill out its pipeline

Last year
Pharma

For­mer Alex­ion VP pleads guilty to in­sid­er trad­ing on Por­to­la buy­out

Last year
Law

Ex­clu­sive: GSK re­vamps its re­search strat­e­gy, build­ing three teams to tar­get spe­cif­ic dis­ease spaces

Last year
R&D
Pharma
First page Previous page 19202122232425 Next page Last page
A service from the Financial Times